These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29178333)

  • 1. Model-Based Reverse Translation Between Veterinary and Human Medicine: The One Health Initiative.
    Schneider B; Balbas-Martinez V; Jergens AE; Troconiz IF; Allenspach K; Mochel JP
    CPT Pharmacometrics Syst Pharmacol; 2018 Feb; 7(2):65-68. PubMed ID: 29178333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse Translation: Using Computational Modeling to Enhance Translational Research.
    Gratz D; Hund TJ; Falvo MJ; Wold LE
    Circ Res; 2018 May; 122(11):1496-1498. PubMed ID: 29798899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-Centered Reverse Translation.
    Wagner JA
    Clin Pharmacol Ther; 2018 Feb; 103(2):168-170. PubMed ID: 29210055
    [No Abstract]   [Full Text] [Related]  

  • 4. Model-Informed Reverse and Forward Translation of Safety Risks in Drug Development.
    Mettetal JT
    Clin Pharmacol Ther; 2018 Feb; 103(2):199-201. PubMed ID: 29194584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bedside to Bench: Integrating Quantitative Clinical Pharmacology and Reverse Translation to Optimize Drug Development.
    Gibbs JP; Menon R; Kasichayanula S
    Clin Pharmacol Ther; 2018 Feb; 103(2):196-198. PubMed ID: 29105747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse Translation for Assessment of Confidence in Animal Models of Multiple Sclerosis for Drug Discovery.
    't Hart BA; Laman JD; Kap YS
    Clin Pharmacol Ther; 2018 Feb; 103(2):262-270. PubMed ID: 28748631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Well Are We Applying Quantitative Methods to Reverse Translation to Inform Early Clinical Development?
    Heatherington AC; Kasichayanula S; Venkatakrishnan K
    Clin Pharmacol Ther; 2018 Feb; 103(2):174-176. PubMed ID: 29274086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rodent models for human diseases.
    Vandamme TF
    Eur J Pharmacol; 2015 Jul; 759():84-9. PubMed ID: 25823811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse Translation: The Art of Cyclical Learning.
    Kasichayanula S; Venkatakrishnan K
    Clin Pharmacol Ther; 2018 Feb; 103(2):152-159. PubMed ID: 29313963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse Translation of US Food and Drug Administration Reviews of Oncology New Molecular Entities Approved in 2011-2017: Lessons Learned for Anticancer Drug Development.
    Faucette S; Wagh S; Trivedi A; Venkatakrishnan K; Gupta N
    Clin Transl Sci; 2018 Mar; 11(2):123-146. PubMed ID: 29266809
    [No Abstract]   [Full Text] [Related]  

  • 11. Reverse Translation in PBPK and QSP: Going Backwards in Order to Go Forward With Confidence.
    Rostami-Hodjegan A
    Clin Pharmacol Ther; 2018 Feb; 103(2):224-232. PubMed ID: 29023678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational medicine between human and veterinary emergency and critical care medicine: a story meant to have a happy ending.
    Félix NM; Gommeren K; Boysen S
    Crit Care; 2019 Nov; 23(1):361. PubMed ID: 31744525
    [No Abstract]   [Full Text] [Related]  

  • 13. Leveraging Humanized Animal Models to Understand Human Drug Disposition: Opportunities, Challenges, and Future Directions.
    Choo EF; Salphati L
    Clin Pharmacol Ther; 2018 Feb; 103(2):188-192. PubMed ID: 29193027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Pharmacology and Translational Aspects of Bispecific Antibodies.
    Trivedi A; Stienen S; Zhu M; Li H; Yuraszeck T; Gibbs J; Heath T; Loberg R; Kasichayanula S
    Clin Transl Sci; 2017 May; 10(3):147-162. PubMed ID: 28297195
    [No Abstract]   [Full Text] [Related]  

  • 15. Perspectives in molecular imaging through translational research, human medicine, and veterinary medicine.
    Berry CR; Garg P
    Semin Nucl Med; 2014 Jan; 44(1):66-75. PubMed ID: 24314047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of preclinical animal models for autoimmune-mediated disorders via reverse translation of failed therapies.
    't Hart BA; Jagessar SA; Kap YS; Haanstra KG; Philippens IH; Serguera C; Langermans J; Vierboom M
    Drug Discov Today; 2014 Sep; 19(9):1394-401. PubMed ID: 24704460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing Clinical Prediction Models: Pushing the Needle Towards Precision Pharmacotherapy.
    Dorajoo SR; Chan A
    Clin Pharmacol Ther; 2018 Feb; 103(2):180-183. PubMed ID: 28722146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of transplant immunosuppressive agents - considerations in the use of animal models.
    Costello R; Kissenpfennig A; Martins PN; McDaid J
    Expert Opin Drug Discov; 2018 Nov; 13(11):1041-1053. PubMed ID: 30332905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy From Strange Sources.
    Lesko LJ
    Clin Pharmacol Ther; 2018 Feb; 103(2):253-261. PubMed ID: 29052220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data.
    Conrado DJ; Duvvuri S; Geerts H; Burton J; Biesdorf C; Ahamadi M; Macha S; Hather G; Francisco Morales J; Podichetty J; Nicholas T; Stephenson D; Trame M; Romero K; Corrigan B;
    Clin Pharmacol Ther; 2020 Apr; 107(4):796-805. PubMed ID: 31955409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.